Ubiquinone Market by Production method (Microbial Fermentation and Chemical Synthesis), Application (Dietary supplements, Pharmaceuticals and Cosmetics): Global Opportunity Analysis and Industry Forecast, 2021–2030
- ALL4676800
- 200 Pages
- August 2021
- Food and Beverages
Ubiquinone which is also known as coenzyme Q10 (CoQ10) is naturally occurring vitamin-like substance which is present in animals, plants, and human body. In human body, it is found in heart, kidney, liver, and pancreas. Ubiquinone is also industrially manufactured by two production methods including microbial fermentation and chemical synthesis. Additionally, it is largely used in the treatment of heart conditions such as congestive heart failure and other diseases such as Huntington’s disease, breast cancer, gum diseases and others. It is commonly used in tablets, supplements, and capsules in pharmaceuticals and nutraceuticals industries.
Adoption of ubiquinone in the Nutraceuticals Industry is driving the growth of the market in terms of value sales. Additionally, the use of ubiquinone in making cosmetic product such as anti-ageing cream and lotions has driven the market growth. However, the easy availability of substitutes for ubiquinone in the market to be used as an ingredient is likely to hamper the growth of the market. Nevertheless, various health benefits associated with ubiquinone in treating various diseases is a major factor which is likely to drive the demand for the ubiquinone from the pharmaceutical industry. market growth. Additionally the rapid growth of online retail platform is expected to offer immense opportunities for the sale of ubiquinone as a dietary supplement in the market. This likely to offer immense opportunity for the growth of ubiquinone market in terms of value sales during the forecast period.
The global ubiquinone equipment market is segmented on t are categorized into production method, application and region. By production method, it is classified into microbial fermentation and chemical synthesis. By application, it is divided into pharmaceuticals, Dietary supplements and cosmetics. Region wise, the market is analyzed across North America (the U.S., Canada and Mexico), Europe (Germany, the UK, France, Italy, Spain Russia and rest of Europe), Asia-Pacific (China, Japan, India, Australia & New Zealand, South Korea, ASEAN and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, Turkey and Rest of LAMEA).
Some of the major players in the global ubiquinone industry analyzed in this report include Hangzhou Jinlan Pharm-Drugs Technology Co., Ltd., Kaneka Corporation, Kyowa Hakko Bio Co., Ltd., Oriental Yeast Co., Ltd., Shandong Octagon Chemicals Limited, Shenzhou Biology & Technology Co., Ltd., Sinoway Industrial Co., Ltd., Spectrum Chemical Manufacturing Corp., Tokiwa Phytochemical Co., Ltd. and Xiamen Kingdomway Group Company.
Key Benefits for Stakeholders
• This report provides a quantitative analysis of the current ubiquinone market trends, estimations, and dynamics of the global ubiquinone market from 2020 to 2030 to identify the prevailing market opportunities.
• The key countries in all the major regions are mapped based on their market share.
• Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier–buyer network.
• In-depth analysis of the market segmentation assists in determining the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global industry. Market player positioning segment facilitates benchmarking and provides a clear understanding of the present position of market players.
• The report includes the analysis of the regional as well as global market, key players, market segments, end use, and growth strategies.
KEY MARKET SEGMENTS
• By Production method
o Microbial Fermentation
o Chemical Synthesis
• By Application
o Dietary Supplements
o Pharmaceuticals
o Cosmetics
• By Region
o North America
U.S.
Canada
Mexico
o Europe
Germany
UK
France
Italy
Spain
Russia
Rest of Europe
o Asia-Pacific
China
India
Japan
Australia & New Zealand
South Korea
ASEAN
Rest of Asia-Pacific
o LAMEA
Brazil
Saudi Arabia
South Africa
Turkey
Rest of LAMEA
o
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.COVID-19 impact on ubiquinone market
3.5.Value chain Analysis
3.6.Top Impacting Factors
3.7.Parent Market Analysis
3.8.Market dynamics
3.8.1.Drivers
3.8.1.1.Rising adoption of ubiquinone in nutraceuticals industry
3.8.1.2.Growing usage of ubiquinone in cosmetic industry
3.8.1.3.Upsurge in the usage of ubiquinone in the Food Industry
3.8.2.Restraint
3.8.2.1.Lack of consumer awareness regarding availability of ubiquinone as a dietary supplement
3.8.2.2.Availability of counterfeit products
3.8.3.Opportunities
3.8.3.1.Rising usage of ubiquinone in pharmaceutical Industry
3.8.3.2.Rapid growth of online retail platform
CHAPTER 4:UBIQUINONE MARKET, BY PRODUCTION METHOD
4.1.Overview
4.1.1.Market size and forecast
4.2.Microbial Fermentation
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country
4.3.Chemical synthesis
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
CHAPTER 5:UBIQUINONE MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Dietary supplements
5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast
5.2.3.Market analysis, by country
5.3.Pharmaceuticals
5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast
5.3.3.Market analysis, by country
5.4.Cosmetics
5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast
5.4.3.Market analysis, by country
CHAPTER 6:UBIQUINONE MARKET, BY REGION
6.1.Overview
6.1.1.Market size and forecast, by region
6.2.North America
6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by production method
6.2.3.Market size and forecast, by application
6.2.4.Market size and forecast, by country
6.2.4.1.U.S.
6.2.4.1.1.Market size and forecast, by production method
6.2.4.1.2.Market size and forecast, by application
6.2.4.2.Canada
6.2.4.2.1.Market size and forecast, by production method
6.2.4.2.2.Market size and forecast, by application
6.2.4.3.Mexico
6.2.4.3.1.Market size and forecast, by production method
6.2.4.3.2.Market size and forecast, by application
6.3.Europe
6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by production method
6.3.3.Market size and forecast, by application
6.3.4.Market size and forecast, by country
6.3.4.1.Germany
6.3.4.1.1.Market size and forecast, by production method
6.3.4.1.2.Market size and forecast, by Application
6.3.4.2.UK
6.3.4.2.1.Market size and forecast, by production method
6.3.4.2.2.Market size and forecast, by application
6.3.4.3.France
6.3.4.3.1.Market size and forecast, by production method
6.3.4.3.2.Market size and forecast, by Application
6.3.4.4.Italy
6.3.4.4.1.Market size and forecast, by production method
6.3.4.4.2.Market size and forecast, by application
6.3.4.5.Spain
6.3.4.5.1.Market size and forecast, by production method
6.3.4.5.2.Market size and forecast, by Application
6.3.4.6.Russia
6.3.4.6.1.Market size and forecast, by production method
6.3.4.6.2.Market size and forecast, by application
6.3.4.7.Rest of Europe
6.3.4.7.1.Market size and forecast, by production method
6.3.4.7.2.Market size and forecast, by application
6.4.Asia-Pacific
6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by production method
6.4.3.Market size and forecast, by application
6.4.4.Market size and forecast, by country
6.4.4.2.Japan
6.4.4.2.1.Market size and forecast, by production method
6.4.4.2.2.Market size and forecast, by application
6.4.4.3.India
6.4.4.3.1.Market size and forecast, by production method
6.4.4.3.2.Market size and forecast, by application
6.4.4.4.China
6.4.4.4.1.Market size and forecast, by production method
6.4.4.4.2.Market size and forecast, by application
6.4.4.5.Australia & New Zealand
6.4.4.5.1.Market size and forecast, by production method
6.4.4.5.2.Market size and forecast, by application
6.4.4.6.ASEAN
6.4.4.6.1.Market size and forecast, by production method
6.4.4.6.2.Market size and forecast, by application
6.4.4.7.South Korea
6.4.4.7.1.Market size and forecast, by production method
6.4.4.7.2.Market size and forecast, by application
6.4.4.8.Rest of Asia-Pacific
6.4.4.8.1.Market size and forecast, by production method
6.4.4.8.2.Market size and forecast, by application
6.5.LAMEA
6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast, by production method
6.5.3.Market size and forecast, by application
6.5.4.Market size and forecast, by country
6.5.4.1.Brazil
6.5.4.1.1.Market size and forecast, by production method
6.5.4.1.2.Market size and forecast, by application
6.5.4.2.Saudi Arabia
6.5.4.2.1.Market size and forecast, by production method
6.5.4.2.2.Market size and forecast, by application
6.5.4.3.South Africa
6.5.4.3.1.Market size and forecast, by production method
6.5.4.3.2.Market size and forecast, by application
6.5.4.4.Turkey
6.5.4.4.1.Market size and forecast, by production method
6.5.4.4.2.Market size and forecast, by application
6.5.4.5.Rest of LAMEA
6.5.4.5.1.Market size and forecast, by production method
6.5.4.5.2.Market size and forecast, by application
6.6.Top Player Positioning
6.7.Competitive dashboard
6.8.Competitive heat map
CHAPTER 7:COMPANY PROFILES
7.1.HANGZHOU JINLAN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO., LTD.
7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Product portfolio
7.2.KANEKA CORPORATION
7.2.1.Company overview
7.2.2.Key Executives
7.2.3.Company snapshot
7.2.4.Operating business segments
7.2.5.Product portfolio
7.2.6.Business performance
7.3.KYOWA HAKKO BIO CO., LTD.
7.3.1.Company overview
7.3.2.Key Executives
7.3.3.Company snapshot
7.3.4.Product portfolio
7.4.ORIENTAL YEAST CO., LTD.
7.4.1.Company overview
7.4.2.Key Executives
7.4.3.Company snapshot
7.4.4.Product portfolio
7.5.SHANDONG OCTAGON CHEMICALS LIMITED
7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Product portfolio
7.6.SHENZHOU BIOLOGY & TECHNOLOGY CO., LTD.
7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Product portfolio
7.7.SINOWAY INDUSTRIAL CO., LTD.
7.7.1.Company overview
7.7.2.Key Executives
7.7.3.Company snapshot
7.7.4.Product portfolio
7.8.SPECTRUM CHEMICAL MANUFACTURING CORP.
7.8.1.Company overview
7.8.2.Key Executives
7.8.3.Company snapshot
7.8.4.Product portfolio
7.9.TOKIWA PHYTOCHEMICAL CO., LTD.
7.9.1.Company overview
7.9.2.Key Executives
7.9.3.Company snapshot
7.9.4.Product portfolio
7.10.XIAMEN KINGDOMWAY GROUP COMPANY
7.10.1.Company overview
7.10.2.Key Executives
7.10.3.Company snapshot
7.10.4.Product portfolio
7.10.5.Key strategic moves and developments
7.10.5.1.DISCLAIMER
TABLE 01.UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 02.MICROBIAL FERMENTATION MARKET REVENUE, BY REGION, 2020–2030 ($MILLION)
TABLE 03.CHEMICAL SYNTHESIS UBIQUINONE MARKET REVENUE, BY REGION, 2020–2030 ($MILLION)
TABLE 04.UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 05.DIETARY SUPPLEMENTS UBIQUINONE MARKET REVENUE, BY REGION, 2020–2030 ($MILLION)
TABLE 06.PHARMACEUTICALS UBIQUINONE MARKET REVENUE, BY REGION, 2020–2030 ($MILLION)
TABLE 07.COSMETICS UBIQUINONE MARKET REVENUE, BY REGION, 2020–2030 ($MILLION)
TABLE 08.UBIQUINONE MARKET REVENUE, BY REGION, 2020–2030 ($MILLION)
TABLE 09.NORTH AMERICA UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 10.NORTH AMERICA UBIQUINONE MARKET REVENUE, BY APPLICATION , 2020-2030($MILLION)
TABLE 11.NORTH AMERICA UBIQUINONE MARKET REVENUE, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 12.U.S. UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 13.U.S UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 14.CANADA UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 15.CANADA UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 16.MEXICO UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 17.MEXICO UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 18.EUROPE UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 19.EUROPE UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 20.EUROPE UBIQUINONE MARKET REVENUE, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 21.GERMANY UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 22.GERMANY UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 23.UK UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 24.UK UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 25.FRANCE UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 26.FRANCE UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 27.ITALY UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 28.ITALY UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 29.SPAIN UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 30.SPAIN UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 31.RUSSIA UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 32.RUSSIA UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 33.REST OF EUROPE UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 34.REST OF EUROPE UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 35.ASIA-PACIFIC UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 36.ASIA-PACIFIC UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 37.ASIA-PACIFIC UBIQUINONE MARKET REVENUE, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 38.JAPAN UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 39.JAPAN UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 40.INDIA UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 41.INDIA UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 42.CHINA UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 43.CHINA UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 44.AUSTRALIA & NEW ZEALAND UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 45.AUSTRALIA & NEW ZEALAND UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 46.ASEAN UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 47.ASEAN UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 48.SOUTH KOREA UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 49.SOUTH KOREA UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 50.REST OF ASIA-PACIFIC UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 51.REST OF ASIA-PACIFIC UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 52.LAMEA UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 53.LAMEA UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 54.LAMEA UBIQUINONE MARKET REVENUE, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 55.BRAZIL UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 56.BRAZIL UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 57.SAUDI ARABIA UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 58.SAUDI ARABIA UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 59.SOUTH AFRICA UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 60.SOUTH AFRICA UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 61.TURKEY UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 62.TURKEY UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 63.REST OF LAMEA UBIQUINONE MARKET REVENUE, BY PRODUCTION METHOD, 2020–2030 ($MILLION)
TABLE 64.REST OF LAMEA UBIQUINONE MARKET REVENUE, BY APPLICATION, 2020-2030($MILLION)
TABLE 65.HANGZHOU JINLAN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO., LTD.: COMPANY SNAPSHOT
TABLE 66.HANGZHOU JINLAN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO., LTD.: PRODUCT PORTFOLIO
TABLE 67.KANEKA CORPORATION: KEY EXECUTIVES
TABLE 68.KANEKA CORPORATION: COMPANY SNAPSHOT
TABLE 69.KANEKA CORPORATION: OPERATING SEGMENTS
TABLE 70.KANEKA CORPORATION: PRODUCT PORTFOLIO
TABLE 71.KANEKA CORPORATION: NET SALES, 2019–2020 ($MILLION)
TABLE 72.KYOWA HAKKO BIO CO., LTD.: KEY EXECUTIVES
TABLE 73.KYOWA HAKKO BIO CO., LTD.: COMPANY SNAPSHOT
TABLE 74.KYOWA HAKKO BIO CO., LTD.: PRODUCT PORTFOLIO
TABLE 75.ORIENTAL YEAST CO., LTD.: KEY EXECUTIVES
TABLE 76.ORIENTAL YEAST CO., LTD.: COMPANY SNAPSHOT
TABLE 77.ORIENTAL YEAST CO., LTD.: PRODUCT PORTFOLIO
TABLE 78.SHANDONG OCTAGON CHEMICALS LIMITED: COMPANY SNAPSHOT
TABLE 79.SHANDONG OCTAGON CHEMICALS LIMITED: PRODUCT PORTFOLIO
TABLE 80.SHENZHOU BIOLOGY & TECHNOLOGY CO., LTD.: COMPANY SNAPSHOT
TABLE 81.SHENZHOU BIOLOGY & TECHNOLOGY CO., LTD.: PRODUCT PORTFOLIO
TABLE 82.SINOWAY INDUSTRIAL CO., LTD.: KEY EXECUTIVES
TABLE 83.SINOWAY INDUSTRIAL CO., LTD.: COMPANY SNAPSHOT
TABLE 84.SINOWAY INDUSTRIAL CO., LTD.: PRODUCT PORTFOLIO
TABLE 85.SPECTRUM CHEMICAL MANUFACTURING CORP.: KEY EXECUTIVES
TABLE 86.SPECTRUM CHEMICAL MANUFACTURING CORP.: COMPANY SNAPSHOT
TABLE 87.SPECTRUM CHEMICAL MANUFACTURING CORP.: PRODUCT PORTFOLIO
TABLE 88.TOKIWA PHYTOCHEMICAL CO., LTD.: KEY EXECUTIVES
TABLE 89.TOKIWA PHYTOCHEMICAL CO., LTD.: COMPANY SNAPSHOT
TABLE 90.TOKIWA PHYTOCHEMICAL CO, LTD: PRODUCT PORTFOLIO
TABLE 91.XIAMEN KINGDOMWAY GROUP COMPANY: KEY EXECUTIVES
TABLE 92.XIAMEN KINGDOMWAY GROUP COMPANY: COMPANY SNAPSHOT
TABLE 93.XIAMEN KINGDOMWAY GROUP COMPANY: PRODUCT PORTFOLIO
Similar Reports
According to FAO, aquaculture, also known as aqua farming, is defined as the farming of aquatic organisms such as fish, mollusks, crustaceans, and aquatic plants. Farming implies intervention in the rearing process to enhance production, such as regular stocki...
- Publish Date: December 12, 2016
- $5370
In the year 2015, the global organic food and beverages market accounted for $115,984 million, and is estimated to grow at a CAGR of 16.4% to reach $327,600 million by 2022. Organic foods are produced by organic farming, which uses natural fertilizers and trad...
- Publish Date: December 19, 2016
- $5370
Animal nutrition chemicals are supplements given to animals that corrects deficiencies in feed and dietary supplementation. In addition, animal nutrition chemicals improve animal’s immunity, pregnancy outcome, fertility, newborn survival and growth, meat...
- Publish Date: June 29, 2018
- $5370
